CN105462891B - Application of the sophora tonkinensis Gapnep endogenetic bacteria B21 in prevention and treatment notoginseng root rot - Google Patents

Application of the sophora tonkinensis Gapnep endogenetic bacteria B21 in prevention and treatment notoginseng root rot Download PDF

Info

Publication number
CN105462891B
CN105462891B CN201510979070.0A CN201510979070A CN105462891B CN 105462891 B CN105462891 B CN 105462891B CN 201510979070 A CN201510979070 A CN 201510979070A CN 105462891 B CN105462891 B CN 105462891B
Authority
CN
China
Prior art keywords
sophora tonkinensis
tonkinensis gapnep
endogenetic bacteria
root rot
metabolite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510979070.0A
Other languages
Chinese (zh)
Other versions
CN105462891A (en
Inventor
黄荣韶
蓝芳
姚裕群
李良波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangxi University
Original Assignee
Guangxi University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi University filed Critical Guangxi University
Priority to CN201510979070.0A priority Critical patent/CN105462891B/en
Publication of CN105462891A publication Critical patent/CN105462891A/en
Application granted granted Critical
Publication of CN105462891B publication Critical patent/CN105462891B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/10Animals; Substances produced thereby or obtained therefrom
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria

Abstract

The invention discloses a kind of sophora tonkinensis Gapnep endogenetic bacteria B21, the classification naming of sophora tonkinensis Gapnep endophyte B21 is bulkholderia cepasea (Burkholderia sp.) B21, the 16S rDNA gene order table of bacterial strain is as described in SEQ ID NO.1, depositary institution: China Committee for Culture Collection of Microorganisms's common micro-organisms center, preservation address: Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3 Institute of Microorganism, Academia Sinica, preservation date: on May 13rd, 2015, deposit number: CGMCC No.10806.The present invention for the first time from the root of medicinal plant sophora tonkinensis Gapnep separation screening to one plant of endogenetic bacteria (Burkholderia sp.) B21, the bacterium has very strong inhibiting effect to notoginseng root rot bacterium, brings wide application prospect for the field of biological control of Radix Notoginseng fungal disease.

Description

Application of the sophora tonkinensis Gapnep endogenetic bacteria B21 in prevention and treatment notoginseng root rot
Technical field
The present invention relates to field of biotechnology, in particular to a kind of sophora tonkinensis Gapnep endogenetic bacteria B21 is in prevention and treatment notoginseng root rot In application.
Background technique
Modern agriculture is overly dependent upon the use of chemical pesticide to the prevention and treatment of plant disease, and the release of a large amount of chemical pesticides is not Only there is long-term destruction to ecological environment, also quality of agricultural product is caused to decline, excessive pesticide residues, the drug resistance of pathogen Property and to problems such as people and animals' nocuousness.It finds safer, effective pest control method to be of great significance, utilize The method of biology, which carrys out controlling plant diseases, effectively to solve the above problems.
Radix Notoginseng (Panax notoginseng F.H.chen) also known as pseudo-ginseng, invaluable etc., have significant activating microcirculation and removing stasis medicinal, Detumescence ding-tong effect is a kind of Chinese tradition rare medicinal herbs.Using Radix Notoginseng as Chinese patent drug made of primary raw material such as " Yunnan Baiyao " " Pien Tze Huang " etc. is wide-spread.In recent years, the demand to Radix Notoginseng raw material is growing, but the nosomycosis in cultivation Evil has seriously affected Panax notoginseng Growth.Currently, prevention and treatment fungal disease depends on chemical pesticide unduly on notoginseng planting, a large amount of chemistry The use of pesticide not only affects the quality of Radix Notoginseng, also results in a large amount of pesticide residues of pseudo-ginseng.
Notoginseng root rot is one of Radix Notoginseng Major Diseases, is commonly called as " green smelly " in producing region, cardinal symptom be seedling stage bud-rot and The water stain shape lesion of brown of its reed head and bastem junction is until spread to entire stem base portion.Just there is generation in the disease seeding stage, 4, disease in May is stagnated, and the 6-9 month enters rainy season, into onset peak period.There are many types for root rot, it was reported that its symptom Mostly caused by notoginseng root rot bacterium (Fusarium solani) (abbreviation F.solani).This fungal disease is to cause for many years One of the main reason for coming Radix Notoginseng product quality and yield decline.
Traditional Genuine producing area of Radix Notoginseng in Guangxi, due to low altitude area and the meteorological condition of high temperature and humidity, this disease is often Be it is simultaneous, cause Radix Notoginseng a large amount of underproduction even have no harvest, had brought tremendous economic losses to farmer.In order to control This fungal disease is made, a large amount of chemical pesticide is used, and a large amount of pesticide residues of Radix Notoginseng product are caused, serious to polluted Environment has greatly threatened people's health.Therefore, carry out biological control Radix Notoginseng fungal disease to the sustainable development of Radix Notoginseng industry Exhibition is very urgent and necessary.Filter out thus the Antagonistic Fungi of this disease of antagonism to be of great significance simultaneously, screen into And developing and using Antagonistic Fungi is also one of effective control most potential control measure of Radix Notoginseng fungal disease.
The information disclosed in the background technology section is intended only to increase the understanding to general background of the invention, without answering When being considered as recognizing or imply that the information constitutes the prior art already known to those of ordinary skill in the art in any form.
Summary of the invention
The purpose of the present invention is to provide a kind of sophora tonkinensis Gapnep endogenetic bacteria B21 to prevent and treat the application in notoginseng root rot, from And the notoginseng root rot occurred during energy effectively preventing notoginseng planting, to improve the yield and quality of Radix Notoginseng.
To achieve the above object, technical solution provided by the invention is as follows:
The classification naming of a kind of sophora tonkinensis Gapnep endogenetic bacteria B21, sophora tonkinensis Gapnep endophyte B21 are bulkholderia cepasea (Burkholderia sp.) B21, the 16S rDNA gene order table of bacterial strain is as described in SEQ ID NO.1, depositary institution: China Microbiological Culture Collection administration committee common micro-organisms center, preservation address: Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3 Institute of Microorganism, Academia Sinica, preservation date: on May 13rd, 2015, deposit number: CGMCC No.10806.
Preferably, the sophora tonkinensis Gapnep endogenetic bacteria B21 metabolite the preparation method comprises the following steps: by sophora tonkinensis Gapnep endogenetic bacteria B21 is inoculated in NB fluid nutrient medium, and being placed in temperature is 28 DEG C, fermented and cultured 10 days under the conditions of revolving speed is 130r/min, gained Fermentation material is added 2 times of fermentation material of methanol and ultrasound 40min, is then centrifuged for after drying is concentrated under reduced pressure, and takes supernatant decompression dense Contracting obtains the methanol crude extract of strain fermentation object, as sophora tonkinensis Gapnep endogenetic bacteria B21 metabolite.
Preferably, the sophora tonkinensis Gapnep endogenetic bacteria B21 is inoculated in the fluid nutrient medium of NB containing 1000ml.
Preferably, NB fluid nutrient medium 3g containing beef extract, yeast extract 1g, peptone 5g, the sucrose 10g, training Supporting base pH value is 7.0.
Application of the metabolite of sophora tonkinensis Gapnep endogenetic bacteria B21 as obtained by above-mentioned preparation in prevention and treatment notoginseng root rot.
Compared with prior art, the invention has the following beneficial effects:
The present invention for the first time from the root of medicinal plant sophora tonkinensis Gapnep separation screening to one plant of endogenetic bacteria (Burkholderia Sp.) B21, the bacterium have very strong inhibiting effect to notoginseng root rot bacterium, bring for the field of biological control of Radix Notoginseng fungal disease Wide application prospect.
Detailed description of the invention
Fig. 1 is the plate opposite culture of sophora tonkinensis Gapnep endogenetic bacteria B21 and notoginseng root rot of the present invention, and wherein F is Roots of Panax Notoginseng Maize ear rot bacterium (Fusarium solani), a are blank control, and b is experimental group.
Fig. 2 is sophora tonkinensis Gapnep endogenetic bacteria B21 strain morphology feature of the present invention, wherein a1 is colonial morphology, and b1 is thallus shape State.
Fig. 3 is the phylogenetic tree that sophora tonkinensis Gapnep endogenetic bacteria B21 bacterial strain is constructed based on 16S rDNA gene order.
Fig. 4 is that the metabolite of bacterial strain sophora tonkinensis Gapnep endogenetic bacteria B21 according to the present invention is raw to the mycelia of notoginseng root rot bacterium Long inhibitory effect;Wherein the 1st it is classified as the blank control i.e. not PDA plate of drug containing;1st arranges the 2nd~6 as the more bacterium of positive control Clever pulvis;2nd arranges the B21 metabolite that the 2nd~6 is bacterial strain, and concentration is respectively 0.5mg/mL, 1mg/mL, 2mg/mL, 4mg/mL, 8mg/mL;F is notoginseng root rot bacterium Fusarium solani.
Specific embodiment
It is described in detail With reference to embodiment, it is to be understood that protection scope of the present invention is not by specific The limitation of embodiment.Material as used in the following examples, reagent etc., unless otherwise specified, commercially It arrives.Methanol is the commercially available pure methanol of analysis.2X TagMasterMix is purchased from precious bioengineering Co., Ltd (Takara), Primer- 1, Primer-2 is by Hua Da gene chemical synthesis.
Embodiment 1
Separation, the screening and identification of bacterial strain
One, the separation of bacterial strain
Material to be tested: the wild sophora tonkinensis Gapnep of Guangxi Tiandeng County In Limestone Area is picked up from.
Strains tested: it is provided by plant pathology research institute of Guangxi University.
Culture medium: 1000ml NA culture medium: beef extract 3g, yeast extract 1g, peptone 5g, sucrose 10g, agar 15g, pH 7.0。
Surface sterilization: a length of 6-8cm, width is dry to rush for the sophora tonkinensis Gapnep root flowing water flushing 30min of 1-2cm fresh and healthy Net silt air-dries surface moisture, superclean bench is moved on to, sterile then by clean sophora tonkinensis Gapnep root with rinsed with sterile water 2 times Under the conditions of, by sophora tonkinensis Gapnep root volumetric concentration be 75% ethyl alcohol impregnate 1min, rinsed with sterile water 2 times, sodium hypochlorite (effective chlorine 1%) 2min is impregnated, sterile washing 3 times, it is spare that sterile blotting paper blots surface.
The separation of bacterial strain purifies: the good sophora tonkinensis Gapnep root of surface sterilization, under aseptic condition, scrapes off epidermis with sterile wood chip, uses Sterile secateurs cuts off the both ends of sophora tonkinensis Gapnep root, and the sterile pocket knife of remaining part and aseptic nipper separate xylem and bast, point The tissue block for not taking 0.5cm long is shredded with sterile secateurs and sterile water is added to grind, and after grinding sufficiently plus sterile water is settled to 5ml And 10min is stood, take 0.5ml supernatant gradient dilution 10~105Times, take 100 μ L dilutions to be applied on NA plate respectively, often A diluted concentration is repeated 3 times, and takes last time rinsing liquid to be coated on NA plate, as negative control.NA plate is placed in culture 28 DEG C of 24~96h of constant temperature incubation of case, picking different shape bacterium colony are crossed purifying repeatedly, by the bacterial strain of purifying, i.e., raw in sophora tonkinensis Gapnep Bacterium is saved with 20% glycerol.
The sophora tonkinensis Gapnep endogenetic bacteria being separated to is inoculated on LA plate, it is stand-by after being cultivated at 28 DEG C for 24 hours.By Radix Notoginseng root-rot Germ is inoculated in PDA plate, stand-by after cultivating 3 days at 28 DEG C.
Two, it screens
Using tablet face-off method to the primary dcreening operation for carrying out thallus bacteriostatic activity for examination sophora tonkinensis Gapnep endogenetic bacteria.
Firstly, 6mm bacteria cake is made in notoginseng root rot bacterium with sterilization punchers under aseptic condition;In processes, by Radix Notoginseng Pine root fungus bacteria cake is transferred to the center of the culture dish containing NA, will be in the sophora tonkinensis Gapnep that be separated to then in the position apart from bacteria cake 2cm Endophytic bacteria bacterial strain connects a bacterium line, and every plant of endogenetic bacteria repeats 3 wares;In control group, notoginseng root rot bacterium bacteria cake is only connect, Sophora tonkinensis Gapnep endogenetic bacteria is not connect, repeats 3 wares.Then, it is cultivated at 28 DEG C, periodic observation.Culture is covered with to fungi in control group When ware, in processing group, measurement notoginseng root rot bacterium bacteria cake center to notoginseng root rot between sophora tonkinensis Gapnep endogenetic bacteria line center The growth radius of bacterium is processing growth radius;In control group, the growth radius of notoginseng root rot bacterium is control growth radius.Most Afterwards, according to the following formula, bacteriostasis rate is calculated:
It compares increment=control and grows radius-bacteria cake radius
It handles increment=processing and grows radius-bacteria cake radius
As a result 3 plants are obtained to all very strong antagonism sophora tonkinensis Gapnep endogenetic bacteria bacterial strain of notoginseng root rot bacterium inhibiting effect, In one plant of entitled B21, be 71% to the inhibiting rate of notoginseng root rot bacterium.
Three, it identifies
(1) strain morphology feature
Colony morphology characteristic observation: by strain inoculated to be identified on NA culture medium, 28 DEG C of cultures are placed in for 24 hours, observation The colony morphology characteristic of bacterial strain.
Morphological features observation: taking the above-mentioned bacterial strain cultivated on NA culture medium for 24 hours to carry out Gram's staining and microscopy, By observed form result microphotograph, as shown in Figure 2.
(2) bacterial strain 16S rDNA sequence and its phylogenetic analysis
The preparation of DNA profiling:
Reagent: (1) lysis buffer: 1% (w/ of Tris-Ac (pH 7.8) 40mM, NaAc 20mM, EDTA 1mM, SDS v);
(2) 5M NaCl solution.
DNA is extracted:
(a) 1.5ml overnight bacterial culture solution culture is placed in microcentrifugal tube (EP pipe), 12000rpm centrifugation 0.5min discards supernatant liquid, retains sediment;
(b) 400 μ l lysis buffers are added in sediment, is blown and beaten repeatedly with suction pipe and is allowed to be resuspended;
(c) 200ul 5M NaCl is added, mixes well, 12000rpm is centrifuged 10min, takes 600 μ l supernatants;
(d) isometric phenol/chloroform (1:1) is added, mixes, is centrifuged (12000rpm, 10min), supernatant is transferred to separately In one clean EP pipe;
(e) isometric chloroform is added in the supernatant obtained into step (d), mixes, be centrifuged (12000rpm, 10min), Supernatant is transferred in another clean EP pipe;
(f) isometric isopropanol is added in gained supernatant into step (e), mixes, is placed in room temperature 10min, be centrifuged (12000rpm, 15min) discards supernatant liquid, retains sediment;
(g) it is 70% ethanol washing step (f) gained sediment with volumetric concentration, dries, as DNA;
(h) DNA done in step (g) is dissolved in 30 μ l distilled water (ddH2O in), -20 DEG C of preservations.
PCR amplification 16S rDNA sequence:
(1) PCR instrument: ABI 3730-XL DNA sequencer (Applied Biosystems, USA)
(2) amplimer: 27F (5 '-AGAGTTTGATCCTGGCTCAG-3 ') is as shown in SEQ ID NO.2 and 1492R (5 '-GGTTACCTTGTTACGACT-3 ') are as shown in SEQ ID NO.3.
(3) amplification system:
16S rDNA sequence PCR amplification system is as shown in table 1:
Table 1.
Reactant Sample-adding amount
2X TagMasterMix 25μL
Primer-1 1μL
Primer-2 1μL
Template DNA 0.5μL
ddH2O 22.5μL
React total volume 50μL
Note: the Template DNA in table 1 is that DNA profiling is made in DNA obtained by above-mentioned steps (h).
PCR reaction condition is as shown in table 2:
Table 2.
Note: step 2 carries out 30 circulations.
The electrophoresis detection of pcr amplification product:
The Ago-Gel (the 5 μ l/100ml containing Goldview) that deposition condition is 1%, 1 × TBE electrophoretic buffer, 90V Electrophoresis 1 hour, PCR product applied sample amount was 3 μ L, point sample after mixing with 1 μ L Loading dye.
In the ultraviolet lower observation of 254nm as a result, using the DL1000 DNA Marker of TaKaRa company as nucleic acid standard molecular weight Object of reference determines expanding fragment length.Amplified production band should be on the position of reference substance 400-700bp.
PCR product purifying and sequencing: it is carried out by Shenzhen Huada Genetic Technology Co., Ltd.
The building of systematic evolution tree:
The 16S rDNA sequence of the bacterium measured in the 16S rDNA sequence surveyed and GenBank gene pool is compared It is right, correlated series are downloaded according to comparison result.It is by the adjoining algorithm (Neighbor-joining NJ) of MEGA 6.0 System is analyzed and constructs systematic evolution tree, as shown in Figure 3.
As a result:
(1) strain morphology feature
Colony morphology characteristic: bacterial strain bacterium colony is creamy white on NA plate, and surface is smooth, protuberance, and neat in edge is round, It is 2-3mm that 5 days diameters are cultivated on NA plate, as shown in a1 in Fig. 2.
Morphological features: Gram-negative is negative staining, no gemma, thallus direct rod shape, and size is (0.43~0.52) μ M × (0.96~1.32) μm, as shown in b1 in Fig. 2.
(2) bacterial strain 16S rDNA sequence and its phylogenetic analysis
Using bacterial universal primers 27F and 1492R, a 1300-1400bp size is amplified from strain gene group DNA Segment, compared through sequencing and by sequencing result by BLASTn in GenBank.The result shows that bacterial strain B21 with Bacterium in Burkholderia has very high base sequence similitude, therefore downloads Burkholderia in all GenBank Reference strain sequence, be used for Phylogenetic Analysis, with the Pandoraea thiooxydans in Pandoraea (NR116008) and Pandoraea pulmonicola (NR115186) is used as outer group.In the systematic evolution tree of building, B21 It gets together to form end branch with Burkholderia anthina (KM019865).Base similarity system design the result shows that, B21 differs a base, sequence similarity 99.7% with Burkholderia anthina (KM019865).Comprehensive morphological And molecular biological characteristics, bacterial strain is initially identified as Burkholderia sp..
Embodiment 2
Inhibiting effect of the Metabolite to notoginseng root rot bacterium
One, the extraction of the fermented and cultured of bacterial strain and B21 metabolite
Sophora tonkinensis Gapnep endogenetic bacteria B21 is inoculated in the fluid nutrient medium of NB containing 1000ml (beef extract 3g, yeast extract 1g, egg White peptone 5g, sucrose 10g, pH 7.0) 2 liters of conical flasks in, be placed in the training of temperature is 28 DEG C, revolving speed is 130r/min shaker fermentation Support 10 days, gained fermentation material be concentrated under reduced pressure it is dry after, 2 times of fermentation material of methanol is added and uses ultrasonic echography 40min, it is ultrasonic It is centrifuged, gained supernatant after centrifugation is taken to be concentrated under reduced pressure to give the methanol crude extract of strain fermentation object, it is raw as in sophora tonkinensis Gapnep Bacterium B21 metabolite.
Two, inhibiting effect of the sophora tonkinensis Gapnep endogenetic bacteria B21 metabolite to the mycelia growth of notoginseng root rot bacterium
The inhibitory activity that notoginseng root rot bacterium mycelia is grown with the B21 metabolite of mycelia growth method measurement bacterial strain.It will The B21 metabolite and powder of carbendazim (positive control) of bacterial strain are respectively prepared containing 0.5mg/mL, 1mg/mL, 2mg/mL, 4mg/ The drug containing tablet of mL, 8mg/mL concentration B21 metabolite.Aseptically, 6mm bacterium is made in disease fungus with punch Notoginseng root rot bacterium bacteria cake is connected to each drug containing tablet center for processing, with the notoginseng root rot that drug containing tablet center does not connect by cake Bacterium bacteria cake is negative control, and in triplicate, all plates are placed in 28 DEG C of cultures for all processing and control.Drug concentration presses carbendazim The Field information concentration of pulvis is arranged.When negative control covers with culture dish, the life of measurement control bacterium colony and processing bacterium colony respectively Long diameter, and according to the following formula, calculate inhibiting rate:
Negative control increment=negative control growth diameter-bacteria cake diameter
Handle increment=processing growth diameter-bacteria cake diameter
Three, minimal inhibitory concentration of the sophora tonkinensis Gapnep endogenetic bacteria B21 metabolite to notoginseng root rot bacterium
With the B21 metabolite of broth dilution method determination bacterial strain to the minimal inhibitory concentration of notoginseng root rot bacterium.PDA is trained Feeding 5 days notoginseng root rot bacterium pure culture biscuits involvng inoculations are in the PDB fluid nutrient medium containing 0.2% Tween 80 (v/v), and 28 DEG C, 150r/ Min shaking table culture 7 days, culture is then gone into triangular flask, and pours into the aseptic double-distilled water containing 0.2% Tween 80, with magnetism Stick stirs 30min, and solution is filtered with sterile gauze, obtains spores solution, and arrived spore concentration adjusting with blood counting chamber Every milliliter 104A spore is spare.The metabolite of bacterial strain is dissolved into the metabolite concentration for the treatment of of 80mg/mL with 1%DMSO, 5 sterile test tubes are taken to be sequentially arranged on rack for test tube, number is 1,2,3,4,5 respectively, and every pipe is separately added into 1ml and spits containing 0.2% The aseptic double-distilled water of temperature 80, then by the bacterial strain methanol crude extract solution of 1ml 80mg/mL be added in the test tube that number is 1 and according to It is secondary that twice of serial dilution is carried out in each pipe.The above-mentioned gained spores solution (10 of 1ml4A/ml) it is separately added into each pipe, to obtain Obtain B21 metabolite concentration for the treatment of finally: 20mg/ml (1 test tube of number), 10mg/ml (2 test tube of number), 5mg/ml (number 3 test tubes), 2.5mg/ml (4 test tube of number), 1.25mg/ml (5 test tube of number).The 8mg/mL fluorine silicon of the 1%DMSO and 1ml of 1ml Azoles missible oil replace B21 metabolite to execute above-mentioned treatment process respectively and as negative control and positive control, all processing and Control is in triplicate.Finally, 28 DEG C of each pipe, 150r/min shaking table culture 5 days.The MIC value of B21 metabolite is complete inhibition three The minimum crude extract concentration of seven pine root fungus visible growths.
As a result:
In the percent inhibition such as table 3 that bacterial strain sophora tonkinensis Gapnep endophyte B21 metabolite grows notoginseng root rot bacterium mycelia It is shown:
Table 3.
Note: positive control powder of carbendazim contains 50% carbendazim in table 3;* indicates that data pass through single factor test variance point in table The LSD of analysis relatively after, Metabolite and positive control powder of carbendazim are under same concentrations, in P0.05Have in level significant Sex differernce.
The suppression result that the metabolite of bacterial strain sophora tonkinensis Gapnep endophyte B21 grows notoginseng root rot bacterium mycelia shows bacterium The metabolite of strain sophora tonkinensis Gapnep endophyte B21 all has extraordinary inhibitory effect to the mycelia growth of notoginseng root rot bacterium, from Table 3 is it can be seen that the metabolite of sophora tonkinensis Gapnep endophyte B21 inhibits the percentage that notoginseng root rot bacterium F.solani mycelia grows Rate is 54.92-92.46%.Compared with positive control powder of carbendazim, the metabolite of bacterial strain sophora tonkinensis Gapnep endophyte B21, to three The inhibitory effect of seven pine root fungus F.solani mycelia growth slightly below compares.
The minimal inhibitory concentration that bacterial strain B21 metabolite grows notoginseng root rot bacterium is as shown in table 4:
Table 4.
Processing MIC(mg/ml)
F.solani
Flusilazole 0.5
B21 10
Note: positive control Flusilazole active constituent content is 400mg/mL in table.
The minimal inhibitory concentration test result that the metabolite of bacterial strain sophora tonkinensis Gapnep endophyte B21 grows notoginseng root rot bacterium Show that the metabolite of bacterial strain sophora tonkinensis Gapnep endophyte B21 all has stronger inhibiting effect to notoginseng root rot bacterium, it can from table 4 With find out the metabolite of sophora tonkinensis Gapnep endophyte B21 to the minimal inhibitory concentration of notoginseng root rot bacterium F.solani for 10mg/ml, It is 20 times of positive control.
As may be known from Table 3 and Table 4, very strong restraining epiphyte is contained in the metabolite of bacterial strain sophora tonkinensis Gapnep endophyte B21 or is killed true The ingredient of bacterium, therefore, in the bionomic control of notoginseng root rot bacterium, bacterial strain sophora tonkinensis Gapnep endophyte B21 has potentiality outstanding.
The aforementioned description to specific exemplary embodiment of the invention is in order to illustrate and illustration purpose.These descriptions It is not wishing to limit the invention to disclosed precise forms, and it will be apparent that according to the above instruction, can much be changed And variation.The purpose of selecting and describing the exemplary embodiment is that explaining specific principle of the invention and its actually answering With so that those skilled in the art can be realized and utilize a variety of different exemplary implementation schemes of the invention and Various chooses and changes.The scope of the present invention is intended to be limited by claims and its equivalents.

Claims (3)

1. a kind of application of metabolite of sophora tonkinensis Gapnep endogenetic bacteria B21 in prevention and treatment notoginseng root rot, it is characterised in that: Vietnam The classification naming of Chinese scholartree endophyte B21 be bulkholderia cepasea (Burkholderia sp.) B21, deposit number: CGMCC No.10806;
The preparation method of the metabolite of the sophora tonkinensis Gapnep endogenetic bacteria B21: sophora tonkinensis Gapnep endogenetic bacteria B21 is inoculated in liquid In body culture medium, being placed in temperature is 28 DEG C, fermented and cultured 10 days under the conditions of revolving speed is 130r/min, and gained fermentation material is dense through depressurizing After contracting is dry, 2 times of fermentation material of methanol and ultrasound 40min is added, is then centrifuged for, supernatant is taken to be concentrated under reduced pressure to give strain fermentation The methanol crude extract of object, as sophora tonkinensis Gapnep endogenetic bacteria B21 metabolite.
2. application of the metabolite of sophora tonkinensis Gapnep endogenetic bacteria B21 in prevention and treatment notoginseng root rot according to claim 1, Be characterized in that: the sophora tonkinensis Gapnep endogenetic bacteria B21 is inoculated in fluid nutrient medium containing 1000ml.
3. application of the metabolite of sophora tonkinensis Gapnep endogenetic bacteria B21 in prevention and treatment notoginseng root rot according to claim 1, Be characterized in that: the fluid nutrient medium 3g containing beef extract, yeast extract 1g, peptone 5g, sucrose 10g, Medium's PH Value are 7.0。
CN201510979070.0A 2015-12-23 2015-12-23 Application of the sophora tonkinensis Gapnep endogenetic bacteria B21 in prevention and treatment notoginseng root rot Active CN105462891B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510979070.0A CN105462891B (en) 2015-12-23 2015-12-23 Application of the sophora tonkinensis Gapnep endogenetic bacteria B21 in prevention and treatment notoginseng root rot

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510979070.0A CN105462891B (en) 2015-12-23 2015-12-23 Application of the sophora tonkinensis Gapnep endogenetic bacteria B21 in prevention and treatment notoginseng root rot

Publications (2)

Publication Number Publication Date
CN105462891A CN105462891A (en) 2016-04-06
CN105462891B true CN105462891B (en) 2019-01-01

Family

ID=55601053

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510979070.0A Active CN105462891B (en) 2015-12-23 2015-12-23 Application of the sophora tonkinensis Gapnep endogenetic bacteria B21 in prevention and treatment notoginseng root rot

Country Status (1)

Country Link
CN (1) CN105462891B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105462897B (en) * 2015-12-23 2019-01-01 广西大学 Application of the sophora tonkinensis Gapnep endogenetic bacteria B21 in prevention and treatment Radix Notoginseng anthracnose
CN112646754B (en) * 2021-01-22 2023-04-07 云南农业大学 Burkholderia and application thereof in preventing and treating main pathogenic bacteria of panax notoginseng root rot

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010018371A2 (en) * 2008-08-13 2010-02-18 University College Cardiff Consusltants Ltd Antimicrobial agent and method for the production thereof
CN105462897A (en) * 2015-12-23 2016-04-06 广西大学 Application of sophora tonkinensis endophytic bacterium B21 in preventing and controlling panax notoginseng anthracnose
CN105462892A (en) * 2015-12-23 2016-04-06 广西大学 Application of sophora tonkinensis endophytic bacterium B21 in preventing and controlling panax notoginseng black spot

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010018371A2 (en) * 2008-08-13 2010-02-18 University College Cardiff Consusltants Ltd Antimicrobial agent and method for the production thereof
CN105462897A (en) * 2015-12-23 2016-04-06 广西大学 Application of sophora tonkinensis endophytic bacterium B21 in preventing and controlling panax notoginseng anthracnose
CN105462892A (en) * 2015-12-23 2016-04-06 广西大学 Application of sophora tonkinensis endophytic bacterium B21 in preventing and controlling panax notoginseng black spot

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
余贤美等.解磷细菌PSB3的筛选及拮抗作用的研究.《微生物学通报》.2008,第35卷(第9期),摘要. *
解磷细菌PSB3的筛选及拮抗作用的研究;余贤美等;《微生物学通报》;20081208;第35卷(第9期);摘要 *

Also Published As

Publication number Publication date
CN105462891A (en) 2016-04-06

Similar Documents

Publication Publication Date Title
CN104694397B (en) One plant of chaetomium globosum and its application
CN105462850B (en) Application of the sophora tonkinensis Gapnep endogenetic fungus SDTE-P in prevention and treatment notoginseng root rot
CN105483020B (en) Application of the sophora tonkinensis Gapnep endogenetic fungus TRXY-34-1 in prevention and treatment notoginseng root rot
CN105462892B (en) Application of the sophora tonkinensis Gapnep endogenetic bacteria B21 in prevention and treatment Alternaria panax
CN105462890B (en) Application of the sophora tonkinensis Gapnep endogenetic bacteria B22 in prevention and treatment notoginseng root rot
CN105462893B (en) Application of the sophora tonkinensis Gapnep endogenetic bacteria B29 in prevention and treatment notoginseng root rot
CN105483041B (en) Application of the sophora tonkinensis Gapnep endogenetic bacteria B22 in prevention and treatment Alternaria panax
CN105462847B (en) Application of the sophora tonkinensis Gapnep endogenetic fungus TRXY-46 in prevention and treatment notoginseng root rot
CN105462854B (en) Application of the sophora tonkinensis Gapnep endogenetic fungus SDTE-P in prevention and treatment Radix Notoginseng anthracnose
CN105462891B (en) Application of the sophora tonkinensis Gapnep endogenetic bacteria B21 in prevention and treatment notoginseng root rot
CN105462897B (en) Application of the sophora tonkinensis Gapnep endogenetic bacteria B21 in prevention and treatment Radix Notoginseng anthracnose
CN105462895B (en) Application of the sophora tonkinensis Gapnep endogenetic bacteria B22 in prevention and treatment Radix Notoginseng anthracnose
CN105462896B (en) Application of the sophora tonkinensis Gapnep endogenetic bacteria B29 in prevention and treatment Alternaria panax
CN104962501B (en) A kind of preparation and application of the bacterial strain, antagonist of anti-vegetable and fruit gray mold
CN104593266B (en) A kind of Endophytic Fungi in Tomato intertexture branch top spore and its application in tomato root-knot eelworm diease occurrence is anti-
CN105462894B (en) Application of the sophora tonkinensis Gapnep endogenetic bacteria B29 in prevention and treatment Radix Notoginseng anthracnose
CN105462851B (en) Application of the sophora tonkinensis Gapnep endogenetic fungus TRXY-59-2 in prevention and treatment notoginseng root rot
CN105483022B (en) Application of the sophora tonkinensis Gapnep endogenetic fungus TRXY-34-1 in prevention and treatment Alternaria panax
CN105483021B (en) Application of the sophora tonkinensis Gapnep endogenetic fungus TRXY-34-1 in prevention and treatment Radix Notoginseng anthracnose
CN105462849B (en) Application of the sophora tonkinensis Gapnep endogenetic fungus TRXY-46 in prevention and treatment Alternaria panax
CN114990020A (en) Biocontrol strain and application thereof
CN105462853B (en) Application of the sophora tonkinensis Gapnep endogenetic fungus TRXY-59-2 in prevention and treatment Radix Notoginseng anthracnose
CN105462852B (en) Application of the sophora tonkinensis Gapnep endogenetic fungus TRXY-46 in prevention and treatment Radix Notoginseng anthracnose
CN114958660A (en) Paenibacillus polymyxa strain and application thereof
CN105462848B (en) Applications of the sophora tonkinensis Gapnep endogenetic fungus TRXY-59-2 in preventing Alternaria panax

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant